Australia to prescribe MDMA and psilocybin for PTSD and depression in world first
Rich Haridy
Nature July 13, 2023 DOI: 10.1038/d41586-023-02093-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Depression MDMA Psilocybin PTSD |
| Keywords | Psychiatric disorders |
| Citations | 55 |
| Key points | The decision to make previously illicit drugs available was rushed. |
Abstract
Decision to make the previously illicit drugs available is dogged by suggestions that it was rushed. Decision to make the previously illicit drugs available is dogged by suggestions that it was rushed.
In the evidence
This study is part of the evidence base for 2 syntheses in the library. Here is how each one recorded it.
-
Reports that Australia's decision to prescribe MDMA and psilocybin for PTSD and depression was dogged by suggestions that it was rushed.
Synthesized
-
Reports that Australia's decision to prescribe MDMA and psilocybin for PTSD and depression was dogged by suggestions it was rushed.
Synthesized